Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
AME vs ITW vs EMR vs ROP vs HON
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
Conglomerates
AME vs ITW vs EMR vs ROP vs HON — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Conglomerates |
| Market Cap | $53.72B | $73.64B | $79.02B | $36.28B | $136.91B |
| Revenue (TTM) | $7.60B | $16.22B | $18.32B | $8.12B | $36.76B |
| Net Income (TTM) | $1.53B | $3.13B | $2.44B | $1.71B | $4.10B |
| Gross Margin | 36.6% | 44.1% | 52.7% | 69.4% | 36.9% |
| Operating Margin | 26.2% | 26.4% | 19.8% | 28.1% | 14.9% |
| Forward P/E | 29.1x | 22.7x | 21.7x | 16.1x | 20.5x |
| Total Debt | $2.28B | $8.97B | $13.76B | $9.30B | $34.58B |
| Cash & Equiv. | $458M | $851M | $1.54B | $297M | $12.49B |
AME vs ITW vs EMR vs ROP vs HON — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AMETEK, Inc. (AME) | 100 | 255.7 | +155.7% |
| Illinois Tool Works… (ITW) | 100 | 148.2 | +48.2% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| Roper Technologies,… (ROP) | 100 | 89.5 | -10.5% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AME vs ITW vs EMR vs ROP vs HON
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AME ranks third and is worth considering specifically for long-term compounding.
- 423.4% 10Y total return vs EMR's 206.6%
- +38.9% vs ROP's -38.0%
ITW is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 12 yrs, beta 0.67, yield 2.4%
- Beta 0.67, yield 2.4%, current ratio 1.21x
- 2.4% yield, 12-year raise streak, vs EMR's 1.5%
- 19.4% ROA vs ROP's 5.0%, ROIC 29.0% vs 6.1%
EMR lags the leaders in this set but could rank higher in a more targeted comparison.
ROP carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 12.3%, EPS growth -1.0%, 3Y rev CAGR 13.7%
- Lower volatility, beta 0.43, Low D/E 46.8%, current ratio 0.52x
- PEG 1.68 vs HON's 11.18
- 12.3% revenue growth vs ITW's 0.9%
Among these 5 stocks, HON doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.3% revenue growth vs ITW's 0.9% | |
| Value | Lower P/E (16.1x vs 20.5x), PEG 1.68 vs 11.18 | |
| Quality / Margins | 21.1% margin vs HON's 11.2% | |
| Stability / Safety | Beta 0.43 vs EMR's 1.52, lower leverage | |
| Dividends | 2.4% yield, 12-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +38.9% vs ROP's -38.0% | |
| Efficiency (ROA) | 19.4% ROA vs ROP's 5.0%, ROIC 29.0% vs 6.1% |
AME vs ITW vs EMR vs ROP vs HON — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AME vs ITW vs EMR vs ROP vs HON — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ROP leads in 2 of 6 categories
AME leads 2 • ITW leads 0 • EMR leads 0 • HON leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ROP leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 4.8x AME's $7.6B. ROP is the more profitable business, keeping 21.1% of every revenue dollar as net income compared to HON's 11.2%. On growth, AME holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $7.6B | $16.2B | $18.3B | $8.1B | $36.8B |
| EBITDAEarnings before interest/tax | $2.3B | $4.6B | $4.7B | $3.2B | $6.5B |
| Net IncomeAfter-tax profit | $1.5B | $3.1B | $2.4B | $1.7B | $4.1B |
| Free Cash FlowCash after capex | $1.7B | $2.2B | $3.1B | $2.6B | $4.2B |
| Gross MarginGross profit ÷ Revenue | +36.6% | +44.1% | +52.7% | +69.4% | +36.9% |
| Operating MarginEBIT ÷ Revenue | +26.2% | +26.4% | +19.8% | +28.1% | +14.9% |
| Net MarginNet income ÷ Revenue | +20.1% | +19.3% | +13.3% | +21.1% | +11.2% |
| FCF MarginFCF ÷ Revenue | +22.4% | +13.6% | +17.0% | +31.4% | +11.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.3% | +4.6% | +2.9% | +11.3% | -6.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +14.5% | +11.8% | +28.2% | +59.1% | -41.9% |
Valuation Metrics
ROP leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 24.4x trailing earnings, ITW trades at a 34% valuation discount to AME's 36.6x P/E. Adjusting for growth (PEG ratio), ITW offers better value at 2.53x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $53.7B | $73.6B | $79.0B | $36.3B | $136.9B |
| Enterprise ValueMkt cap + debt − cash | $55.5B | $81.8B | $91.2B | $45.3B | $159.0B |
| Trailing P/EPrice ÷ TTM EPS | 36.64x | 24.36x | 34.92x | 24.82x | 29.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.08x | 22.68x | 21.71x | 16.08x | 20.52x |
| PEG RatioP/E ÷ EPS growth rate | 3.28x | 2.53x | 7.73x | 2.59x | 15.99x |
| EV / EBITDAEnterprise value multiple | 29.55x | 17.74x | 18.07x | 14.57x | 19.99x |
| Price / SalesMarket cap ÷ Revenue | 7.26x | 4.59x | 4.39x | 4.59x | 3.66x |
| Price / BookPrice ÷ Book value/share | 5.10x | 23.15x | 3.94x | 1.91x | 9.00x |
| Price / FCFMarket cap ÷ FCF | 32.14x | 27.20x | 29.63x | 14.55x | 25.39x |
Profitability & Efficiency
AME leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ITW delivers a 97.4% return on equity — every $100 of shareholder capital generates $97 in annual profit, vs $9 for ROP. AME carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to ITW's 2.78x. On the Piotroski fundamental quality scale (0–9), AME scores 7/9 vs ITW's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.4% | +97.4% | +12.1% | +8.8% | +23.1% |
| ROA (TTM)Return on assets | +9.6% | +19.4% | +5.8% | +5.0% | +5.3% |
| ROICReturn on invested capital | +12.1% | +29.0% | +8.2% | +6.1% | +12.6% |
| ROCEReturn on capital employed | +15.0% | +38.7% | +10.0% | +7.7% | +12.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 7 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.21x | 2.78x | 0.68x | 0.47x | 2.24x |
| Net DebtTotal debt minus cash | $1.8B | $8.1B | $12.2B | $9.0B | $22.1B |
| Cash & Equiv.Liquid assets | $458M | $851M | $1.5B | $297M | $12.5B |
| Total DebtShort + long-term debt | $2.3B | $9.0B | $13.8B | $9.3B | $34.6B |
| Interest CoverageEBIT ÷ Interest expense | 23.34x | 14.53x | 6.46x | 6.50x | 3.92x |
Total Returns (Dividends Reinvested)
AME leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AME five years ago would be worth $17,454 today (with dividends reinvested), compared to $8,255 for ROP. Over the past 12 months, AME leads with a +38.9% total return vs ROP's -38.0%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.7% vs ROP's -7.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.3% | +3.1% | +4.3% | -18.5% | +10.9% |
| 1-Year ReturnPast 12 months | +38.9% | +9.0% | +30.4% | -38.0% | +2.8% |
| 3-Year ReturnCumulative with dividends | +64.1% | +19.5% | +75.9% | -21.0% | +16.2% |
| 5-Year ReturnCumulative with dividends | +74.5% | +18.9% | +59.5% | -17.5% | +3.3% |
| 10-Year ReturnCumulative with dividends | +423.4% | +189.4% | +206.6% | +115.0% | +135.1% |
| CAGR (3Y)Annualised 3-year return | +18.0% | +6.1% | +20.7% | -7.6% | +5.1% |
Risk & Volatility
Evenly matched — AME and ROP each lead in 1 of 2 comparable metrics.
Risk & Volatility
ROP is the less volatile stock with a 0.43 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AME currently trades 96.4% from its 52-week high vs ROP's 60.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.93x | 0.67x | 1.52x | 0.43x | 0.74x |
| 52-Week HighHighest price in past year | $243.18 | $303.16 | $165.15 | $584.03 | $248.18 |
| 52-Week LowLowest price in past year | $168.49 | $236.68 | $108.37 | $313.86 | $186.76 |
| % of 52W HighCurrent price vs 52-week peak | +96.4% | +84.3% | +85.4% | +60.3% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 63.3 | 45.3 | 61.3 | 43.6 | 45.1 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 1.2M | 2.8M | 1.2M | 3.7M |
Analyst Outlook
Evenly matched — ITW and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AME as "Buy", ITW as "Hold", EMR as "Buy", ROP as "Buy", HON as "Buy". Consensus price targets imply 29.8% upside for ROP (target: $458) vs 4.9% for AME (target: $246). For income investors, ITW offers the higher dividend yield at 2.39% vs AME's 0.53%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $245.91 | $273.67 | $161.92 | $457.64 | $243.83 |
| # AnalystsCovering analysts | 29 | 28 | 41 | 23 | 28 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +2.4% | +1.5% | +0.9% | +2.1% |
| Dividend StreakConsecutive years of raises | 16 | 12 | 37 | 12 | 15 |
| Dividend / ShareAnnual DPS | $1.23 | $6.11 | $2.10 | $3.29 | $4.63 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.8% | +2.0% | +1.6% | +1.4% | +2.8% |
ROP leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). AME leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
AME vs ITW vs EMR vs ROP vs HON: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AME or ITW or EMR or ROP or HON a better buy right now?
For growth investors, Roper Technologies, Inc.
(ROP) is the stronger pick with 12. 3% revenue growth year-over-year, versus 0. 9% for Illinois Tool Works Inc. (ITW). Illinois Tool Works Inc. (ITW) offers the better valuation at 24. 4x trailing P/E (22. 7x forward), making it the more compelling value choice. Analysts rate AMETEK, Inc. (AME) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AME or ITW or EMR or ROP or HON?
On trailing P/E, Illinois Tool Works Inc.
(ITW) is the cheapest at 24. 4x versus AMETEK, Inc. at 36. 6x. On forward P/E, Roper Technologies, Inc. is actually cheaper at 16. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Roper Technologies, Inc. wins at 1. 68x versus Honeywell International Inc. 's 11. 18x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AME or ITW or EMR or ROP or HON?
Over the past 5 years, AMETEK, Inc.
(AME) delivered a total return of +74. 5%, compared to -17. 5% for Roper Technologies, Inc. (ROP). Over 10 years, the gap is even starker: AME returned +423. 4% versus ROP's +115. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AME or ITW or EMR or ROP or HON?
By beta (market sensitivity over 5 years), Roper Technologies, Inc.
(ROP) is the lower-risk stock at 0. 43β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 256% more volatile than ROP relative to the S&P 500. On balance sheet safety, AMETEK, Inc. (AME) carries a lower debt/equity ratio of 21% versus 3% for Illinois Tool Works Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AME or ITW or EMR or ROP or HON?
By revenue growth (latest reported year), Roper Technologies, Inc.
(ROP) is pulling ahead at 12. 3% versus 0. 9% for Illinois Tool Works Inc. (ITW). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, ROP leads at 13. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AME or ITW or EMR or ROP or HON?
AMETEK, Inc.
(AME) is the more profitable company, earning 20. 0% net margin versus 12. 6% for Honeywell International Inc. — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ROP leads at 28. 3% versus 17. 5% for HON. At the gross margin level — before operating expenses — ROP leads at 69. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AME or ITW or EMR or ROP or HON more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Roper Technologies, Inc. (ROP) is the more undervalued stock at a PEG of 1. 68x versus Honeywell International Inc. 's 11. 18x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Roper Technologies, Inc. (ROP) trades at 16. 1x forward P/E versus 29. 1x for AMETEK, Inc. — 13. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ROP: 29. 8% to $457. 64.
08Which pays a better dividend — AME or ITW or EMR or ROP or HON?
All stocks in this comparison pay dividends.
Illinois Tool Works Inc. (ITW) offers the highest yield at 2. 4%, versus 0. 5% for AMETEK, Inc. (AME).
09Is AME or ITW or EMR or ROP or HON better for a retirement portfolio?
For long-horizon retirement investors, Roper Technologies, Inc.
(ROP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 43), 0. 9% yield, +115. 0% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ROP: +115. 0%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AME and ITW and EMR and ROP and HON?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.